Boundless Bio gets FDA clearance for cancer drug trial
Go back to Boundless Bio gets FDA clearance for cancer drug trial| Bold Energy, Inc. (NASDAQ: BOLD) | Delayed: 2.48 -0.01 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.49 | 52 Week High | $20.74 | |||
| Open | $2.50 | 52 Week Low | $13.06 | |||
| Day High | $2.51 | P/E | N/A | |||
| Day Low | $2.44 | EPS | $0.00 | |||
| Volume | 102,934 | |||||
